Application 212627
- Type
- ANDA
- Sponsor
- NIVAGEN PHARMS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | SOLUTION;INTRAVENOUS | 5MG/10ML (0.5MG/ML) | No | No |
| 002 | NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | SOLUTION;INTRAVENOUS | 10MG/10ML (1MG/ML) | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 75834-149 | NEOSTIGMINE METHYLSULFATE | neostigmine methylsulfate | Nivagen Pharmaceuticals, Inc. | ANDA | Current |
| 75834-150 | NEOSTIGMINE METHYLSULFATE | neostigmine methylsulfate | Nivagen Pharmaceuticals, Inc. | ANDA | Current |